The Center for Discovery and Innovation- CDI was established by Hackensack Meridian Health (HMH) as an academic basic and translational research enterprise to rapidly translate science innovation to the clinic and to improve outcomes for patients with cancer, infectious diseases, autoimmune disease and other acute and chronic diseases. The CDI has grown rapidly since its origins in 2019, and now has 39 labs, 200+ scientists and allied personnel supported by 78 NIH and DoD grants and more than 87 other grants and contracts. Areas of expertise include genomics, epigenetics, drug resistance, stem cell biology, drug discovery, diagnostics and biomarker development, rheumatology and pharmacology. The CDI Virology Core is seeking a motivated candidate with training and hands-on experience in molecular virology, preferably with expertise in flaviviruses. The successful candidate will support research on emerging viruses, pandemic preparedness, and antiviral drug discovery. Responsibilities include performing virology and cell-based experiments, analyzing and interpreting data, presenting results, and contributing to the development and execution of experimental procedures. Experience with dengue virus (DENV) reverse genetics, infectious clone systems, virus rescue, reporter viruses, or related flavivirus techniques is highly desirable.

Qualifications:

Education, Knowledge, Skills and Abilities Required:

A Ph.D. degree in scientific or related discipline. Minimum publication or in preparation of one article as first author in a reputable peer-reviewed journal. Excellent written and verbal skills Good problem solving skills. Ability to conduct independent research. Ability to work effectively in a team. Lab specific techniques. (Varies by lab) Proficient computer skills including but not limited to Microsoft Office and Google Suite platforms. If you feel that the above description speaks directly to your strengths and capabilities, then please apply today!